Average Ratings 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

No User Reviews. Be the first to provide a review:

Write a Review

Description

BioSniper serves as a research platform tailored for equity analysts, investors, and professionals in the life sciences sector. Users can articulate their research or investment ideas in straightforward language, and the platform then organizes this input into a systematic workflow that includes various screenings, checks by specialized agents, scoring mechanisms, blocking protocols, and gates for evidence. It conducts searches across seven categories of public sources, which encompass SEC EDGAR filings along with insider trading data, FDA-related events, ClinicalTrials.gov, PubMed, USPTO and Google Patents, biotech news, and market analytics. The platform ensures that findings are linked to their source records, with any gaps or discrepancies in evidence flagged as unknown instead of making assumptions; it also provides the source and applicable dates when they are available. Furthermore, BioSniper includes a complimentary public calendar for biotech events, an SEC cash runway calculator, and an open-source toolkit in Python for users to leverage. In addition to these features, the platform aims to enhance the decision-making process for its users by providing comprehensive access to relevant data.

Description

EquiReason serves as a comprehensive platform for equity research and market intelligence, catering to self-directed investors, independent analysts, and research teams alike. By integrating SEC filings, XBRL financial data, earnings-call transcripts, and extensive market information, it empowers users to analyze financial performance, ownership trends, and overall company exposure. The platform meticulously tracks market events through economic channels, linking them to potentially impacted companies and offering a verdict for each, complete with supporting and counter-arguments. Users can access a variety of research perspectives, which include financial statements, valuation insights, insider and institutional activities, segment revenue details, and alerts specific to each company, with all evidence connected to its original source. Accessible via both web and iPhone app, EquiReason features a free plan alongside paid research options, ensuring users have the necessary tools for informed decision-making. Importantly, the platform focuses on providing research and decision support rather than direct investment advice, enabling users to navigate the complexities of the market with greater confidence.

API Access

Has API No 

API Access

Has API Yes 

Screenshots View All

No images available

Screenshots View All

No images available

Integrations

No details available.

Integrations

No details available.

Pricing Details

$39/month
A free plan is available. Researcher costs $39/month, and Analyst costs $79/month. Monthly AI credit allowances are 200, 3,000, and 10,000 for Free, Researcher, and Analyst, respectively; the plans also differ in research and customization features.
Free Trial No 
Free Version Yes 

Pricing Details

$49/month
Free plan available. Analyst is $49/month; Research Pro is $89/month. Annual billing is ten months for twelve. Research Pro has a seven-day trial with no card required.
Free Trial Yes 
Free Version Yes 

Deployment

Web-Based Yes 
On-Premises No 
iPhone App No 
iPad App No 
Android App No 
Windows No 
Mac No 
Linux No 
Chromebook No 

Deployment

Web-Based Yes 
On-Premises No 
iPhone App Yes 
iPad App No 
Android App No 
Windows No 
Mac No 
Linux No 
Chromebook No 

Customer Support

Business Hours No 
Live Rep (24/7) No 
Online Support Yes 

Customer Support

Business Hours No 
Live Rep (24/7) No 
Online Support No 

Types of Training

Training Docs Yes 
Webinars No 
Live Training (Online) No 
In Person No 

Types of Training

Training Docs No 
Webinars No 
Live Training (Online) No 
In Person No 

Vendor Details

Company Name

BioSniper

Founded

2024

Country

United States

Website

biosniper.co

Vendor Details

Company Name

EquiReason

Founded

2026

Country

Turkey

Website

equireason.com

Product Features

Product Features

Alternatives

Alternatives

Dion Insight Reviews

Dion Insight

Dion Global Solutions
VerityRMS Reviews

VerityRMS

Verity
Sniper AI Reviews

Sniper AI

Recruitment Smart Technologies